selgantolimod   Click here for help

GtoPdb Ligand ID: 10889

Synonyms: compound (R)-7 [PMID: 32407112] | GS-9688 | GS9688
PDB Ligand
Compound class: Synthetic organic
Comment: Selgantolimod (GS-9688) is an investigational, selective and orally active TLR8 agonist [1]. It was designed to treat chronic hepatitis B infection.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 3
Rotatable bonds 6
Topological polar surface area 96.95
Molecular weight 293.17
XLogP 2.03
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES CCCC[C@@](Nc1nc(N)nc2c1ncc(c2)F)(CO)C
Isomeric SMILES CCCC[C@@](Nc1nc(N)nc2c1ncc(c2)F)(CO)C
InChI InChI=1S/C14H20FN5O/c1-3-4-5-14(2,8-21)20-12-11-10(18-13(16)19-12)6-9(15)7-17-11/h6-7,21H,3-5,8H2,1-2H3,(H3,16,18,19,20)/t14-/m1/s1
No information available.
Summary of Clinical Use Click here for help
Gilead have advanced selgantolimod (GS-9688) to Phase 2 clinical evaluation.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT03615066 Safety, Tolerability, and Antiviral Activity of Selgantolimod in Viremic Adults With Chronic Hepatitis B Who Are Not Currently on Treatment Phase 2 Interventional Gilead Sciences
NCT03491553 Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Adults With Chronic Hepatitis B Phase 2 Interventional Gilead Sciences